Form D — Branch Therapeutics, Inc.
0002067625-25-000001 · filed 2025-05-23
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $3,999,994
- Total sold
- $3,999,994
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Branch Therapeutics, Inc.
- CIK
- 2067625
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2450 HOLCOMBE BLVD
HOUSTON, TX 77021 - Phone
- 615-351-1950
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Curtis Thorne · Executive OfficerTucson, AZ Find on LinkedIn ↗
-
Christopher Hulme · DirectorOro Valley, AZ Find on LinkedIn ↗
-
Sourav Banerjee · DirectorInvergowrie Dundee, X0 Find on LinkedIn ↗
View original on SEC EDGAR.